PRE fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Prenetics Global Ltd. is a genomics-driven health sciences company, which engages in the prevention, early detection, and treatment of diseases. It operates through the Prevention and Diagnostic segments. The Prevention segment is involved in the design and sale of genetics testing and stool-based DNA tests for early colorectal cancer screening. The Diagnostic segment consists of COVID-19 testing services and products, and precision oncology services. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
PRE does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company